Physician
Med First Immediate Care & Family Practice, PA
Med First Immediate Care & Family Practice, PA was paid $14.59M by Medicaid between Jan 2018 and Dec 2024, across 99 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 34% of everything it billed.
33Billing provider infoMED FIRST IMMEDIATE CARE & FAMILY PRACTICE, PA
JACKSONVILLE, NC 28540
JACKSONVILLE, NC 28540
33aNPI1053503763assigned 08/16/2007
33bProvider typeFamily Medicine Physician
28Total paid$14.59M
24GClaims1,526,294
24DCodes billed99
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in North Carolina
Rank by total paid#3 of 960
Median peer was paid$135K
This provider vs. median108×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,737 | $870K | |
| 2019 | 21,779 | $849K | |
| 2020 | 24,598 | $758K | |
| 2021 | 79,266 | $1.52M | |
| 2022 | 277,419 | $2.44M | |
| 2023 | 438,741 | $3.07M | |
| 2024incomplete | 661,754 | $5.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 34% | 862,159 | 454,396 | $4.92M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 98,114 | 71,254 | $4.85M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 42,747 | 31,854 | $1.75M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.9% | 11,086 | 8,355 | $720K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.2% | 4,812 | 3,722 | $470K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.2% | 16,557 | 11,428 | $461K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.4% | 3,203 | 2,379 | $211K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 14,471 | 6,034 | $174K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,709 | 1,438 | $108K |
| 87428 | <1% | 2,174 | 1,419 | $95K | |
| 80305 | <1% | 15,037 | 11,627 | $91K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 691 | 645 | $80K |
87 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 855 | $73K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,056 | $73K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,705 | $72K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 711 | $55K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,773 | $53K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 590 | $50K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,385 | $46K |
| 99490 | Ccm add 20min | <1% | 3,185 | $37K |
| 96127 | <1% | 9,542 | $26K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 981 | $26K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,525 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,761 | $22K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 188 | $17K |
| 82947 | <1% | 5,345 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,227 | $9K |
| 81003 | <1% | 6,155 | $9K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,123 | $7K |
| 99406 | <1% | 769 | $5K | |
| 92551 | <1% | 1,539 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 30 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 148 | $4K |
| 87807 | <1% | 333 | $4K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 160 | $3K |
| 80061 | Lipid panel | <1% | 379 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 74 | $3K |
| 20610 | <1% | 216 | $3K | |
| 99173 | <1% | 1,728 | $2K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 31 | $2K |
| 86328 | <1% | 126 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 160 | $2K |
| 99386 | <1% | 17 | $1K | |
| 0011A | <1% | 46 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 88 | $1K |
| 90670 | <1% | 178 | $985.01 | |
| 93000 | <1% | 134 | $826.62 | |
| 0012A | <1% | 13 | $780.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 130 | $635.79 |
| 81025 | <1% | 93 | $634.06 | |
| 0072A | <1% | 13 | $549.58 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 62 | $546.82 |
| 90674 | <1% | 192 | $522.56 | |
| 90461 | <1% | 86 | $514.67 | |
| 90715 | <1% | 25 | $297.78 | |
| 90677 | <1% | 70 | $268.63 | |
| 82570 | <1% | 90 | $263.31 | |
| 82044 | <1% | 91 | $169.47 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 129 | $115.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 183 | $91.88 |
| 99401 | <1% | 20 | $84.00 | |
| 3044F | <1% | 1,110 | $80.00 | |
| 90633 | <1% | 52 | $70.01 | |
| 82962 | <1% | 82 | $50.05 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 20 | $28.80 |
| 90688 | <1% | 120 | $15.47 | |
| 99497 | <1% | 13 | $13.37 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 71 | $11.52 |
| 1111F | <1% | 1,468 | $1.47 | |
| 3074F | <1% | 61,561 | $0.15 | |
| 3078F | <1% | 49,896 | $0.12 | |
| 1160F | <1% | 64,567 | $0.06 | |
| 1159F | <1% | 62,164 | $0.05 | |
| 3079F | <1% | 21,720 | $0.04 | |
| 3075F | <1% | 9,414 | $0.02 | |
| 3077F | <1% | 1,799 | $0.01 | |
| 1126F | <1% | 6,244 | $0.01 | |
| 3080F | <1% | 2,139 | $0.01 | |
| 3725F | 0% | 22,774 | $0.00 | |
| 0521F | 0% | 1,482 | $0.00 | |
| 90648 | 0% | 22 | $0.00 | |
| 90649 | 0% | 16 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 34 | $0.00 |
| 90710 | 0% | 14 | $0.00 | |
| 3062F | 0% | 22 | $0.00 | |
| 1036F | 0% | 46,493 | $0.00 | |
| 3008F | 0% | 27,035 | $0.00 | |
| 1125F | 0% | 2,818 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 95 | $0.00 |
| 1034F | 0% | 11,914 | $0.00 | |
| 94760 | 0% | 68 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 164 | $0.00 |
| 3061F | 0% | 577 | $0.00 | |
| 1101F | 0% | 922 | $0.00 | |
| 90680 | 0% | 37 | $0.00 | |
| 91301 | 0% | 52 | $0.00 | |
| 3060F | 0% | 44 | $0.00 | |
| 90656 | 0% | 37 | $0.00 | |
| 90696 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFENECK, PAUL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Med First Immediate Care & Family Practice, PA | Jacksonville, NC | $102K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.